Profile: Human Genome Sciences, Inc. is a biopharmaceutical company. We offer novel compounds in clinical development including drugs to treat such diseases as hepatitis C, lupus, anthrax disease, cancer, rheumatoid arthritis and HIV/AIDS. Our ABthrax™ is a human monoclonal antibody that blocks the binding to cell surfaces of Bacillus anthracis protective antigen, the key facilitator of anthrax toxicity.